Does Combination Therapy With SGLT2 Inhibitors and Renin–Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes?

Detalles Bibliográficos
Autores principales: Zhao, Li-Min, Zhang, Miao, Zhan, Ze-Lin, Qiu, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131654/
https://www.ncbi.nlm.nih.gov/pubmed/34026878
http://dx.doi.org/10.3389/fcvm.2021.679124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131654/
https://www.ncbi.nlm.nih.gov/pubmed/34026878
http://dx.doi.org/10.3389/fcvm.2021.679124

Ejemplares similares